Geode Capital Management, LLC Soligenix, Inc. Transaction History

Geode Capital Management, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$0.4 - $168.0 $312 - $131,208	-781 Reduced 0.24%	324,709 $146,000
Q3 2022 Nov 14, 2022	BUY	$0.51 - $117.79 $1,862 - $430,169	3,652 Added 1.13%	325,490 $142,000
Q2 2022 Aug 12, 2022	BUY	$0.4 - $0.75 $9,000 - $16,875	22,500 Added 7.52%	321,838 $193,000
Q3 2021 Nov 12, 2021	BUY	$0.9 - $1.31 $49,727 - $72,381	55,253 Added 22.64%	299,338 $317,000
Q2 2021 Aug 13, 2021	BUY	$0.87 - $1.58 $22,227 - $40,367	25,549 Added 11.69%	244,085 $270,000
Q1 2021 May 12, 2021	BUY	$1.31 - $2.35 $118,072 - $211,810	90,132 Added 70.19%	218,536 $334,000
Q3 2020 Nov 13, 2020	BUY	$1.7 - $2.61 $14,994 - $23,020	8,820 Added 7.38%	128,404 $229,000
Q2 2020 Aug 13, 2020	SELL	$1.36 - $2.26 $4,734 - $7,867	-3,481 Reduced 2.83%	119,584 $252,000
Q1 2020 May 14, 2020	BUY	$1.42 - $3.34 $145,929 - $343,241	102,767 Added 506.29%	123,065 $206,000
Q2 2017 Aug 14, 2017	BUY	N/A	20,298	20,298 $42,000

Ticker SNGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,105,200
Market Cap $143M
Description
Soligenix, Inc., a late-stage biopharmaceutical company, focuses on developing and commercializing products to treat rare diseases in the United States. It operates in two segments, Specialized BioTherapeutics and Public Health Solutions. The Specialized BioTherapeutics segment develops SGX301 (HyBryte), a novel photodynamic therapy, which has c...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.